For: | Leowattana W, Leowattana P, Leowattana T. Systemic treatment for metastatic colorectal cancer. World J Gastroenterol 2023; 29(10): 1569-1588 [PMID: 36970592 DOI: 10.3748/wjg.v29.i10.1569] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v29/i10/1569.htm |
Number | Citing Articles |
1 |
Liuxu Yao, Wen Zhai, Zongming Jiang, Rui He, Weiying Xie, Yuhong Li, Yiyang Hu. The Inhibitory Effects of Propofol on Colorectal Cancer Progression through the
NF-κB/HIF-1α Signaling Pathway. Anti-Cancer Agents in Medicinal Chemistry 2024; 24(11): 878 doi: 10.2174/0118715206283884240326170501
|
2 |
Xinying Zhou, Yu Zhao, Rongchuan Zhao, Shaheryar Shafi, Yue Yang, Guangxing Liu, Song-Bai Liu. Research progress of intestinal microbiota in targeted therapy and immunotherapy of colorectal cancer. Journal of Cancer Metastasis and Treatment 2024; doi: 10.20517/2394-4722.2023.178
|
3 |
Fengxiang Huang, Haiyan Yang, Wenguang Bao, Yehong Bin, Shengsheng Zhou, Man Wang, Xiaoping Lv. Efficacy and safety of trifluridine/tipiracil (TAS-102) in patients with metastatic colorectal cancer: a systematic review and meta-analysis. Clinical and Translational Oncology 2023; 26(2): 468 doi: 10.1007/s12094-023-03268-5
|
4 |
Wen-Tao Zhong, Yuan Lv, Qian-Yu Wang, Ran An, Gang Chen, Jun-Feng Du. Chemoradiotherapy plus tislelizumab for mismatch repair proficient rectal cancer with supraclavicular lymph node metastasis: A case report. World Journal of Gastrointestinal Oncology 2024; 16(5): 2219-2224 doi: 10.4251/wjgo.v16.i5.2219
|
5 |
Ghizlane Rais, Farah Boutaagount, Rania Mokfi, Meryem Maskrout, Soundous Bennour, Chaymae Senoussi, Fadoua Rais, Laila Lahlou. The Safety and Effectiveness of Bevacizumab in Metastatic Colorectal Cancer With Unresectable Metastases: A Real-Life Study From the South of Morocco. Cureus 2024; doi: 10.7759/cureus.56733
|
6 |
平 盛. Progress in Surgical Treatment of Colorectal Cancer. Advances in Clinical Medicine 2023; 13(11): 17887 doi: 10.12677/ACM.2023.13112510
|
7 |
Qi Liu, Yajuan Zhang, Huimin Li, Hong Gao, Yijie Zhou, Dakui Luo, Zezhi Shan, Yufei Yang, Junyong Weng, Qingguo Li, Weiwei Yang, Xinxiang Li. Squalene epoxidase promotes the chemoresistance of colorectal cancer via (S)-2,3-epoxysqualene-activated NF-κB. Cell Communication and Signaling 2024; 22(1) doi: 10.1186/s12964-024-01649-z
|
8 |
Yung-Fu Chang, Hsing-Hsang Wang, Chih-Wen Shu, Wei-Lun Tsai, Cheng-Hsin Lee, Chun-Lin Chen, Pei-Feng Liu. TMEM211 Promotes Tumor Progression and Metastasis in Colon Cancer. Current Issues in Molecular Biology 2023; 45(6): 4529 doi: 10.3390/cimb45060287
|
9 |
Qing Cao, Ye Tian, Zhiyi Deng, Fangfang Yang, Erfei Chen. Epigenetic Alteration in Colorectal Cancer: Potential Diagnostic and Prognostic Implications. International Journal of Molecular Sciences 2024; 25(6): 3358 doi: 10.3390/ijms25063358
|
10 |
Edward Zheng, Marcin Włodarczyk, Andrzej Węgiel, Aleksandra Osielczak, Maria Możdżan, Laura Biskup, Agata Grochowska, Maria Wołyniak, Dominik Gajewski, Mateusz Porc, Kasper Maryńczak, Łukasz Dziki. Navigating through novelties concerning mCRC treatment—the role of immunotherapy, chemotherapy, and targeted therapy in mCRC. Frontiers in Surgery 2024; 11 doi: 10.3389/fsurg.2024.1398289
|
11 |
Marco Colella, Andrea Iannucci, Claudia Maresca, Francesco Albano, Carmela Mazzoccoli, Federica Laudisi, Ivan Monteleone, Giovanni Monteleone. SMAD7 Sustains XIAP Expression and Migration of Colorectal Carcinoma Cells. Cancers 2024; 16(13): 2370 doi: 10.3390/cancers16132370
|
12 |
Pengcheng Wang, Wenjin Zhong, Qiaozhen Huang, Yuejia Zhu, Liquan Chen, Kai Ye. Liposome Nanomedicine Based on Tumor Cell Lysate Mitigates the Progression of Lynch Syndrome-Associated Colon Cancer. ACS Biomaterials Science & Engineering 2024; 10(5): 3136 doi: 10.1021/acsbiomaterials.3c01531
|
13 |
Daniel M. DePietro, Xin Li, Susan M. Shamimi-Noori. Chemoembolization Beyond Hepatocellular Carcinoma: What Tumors Can We Treat and When?. Seminars in Interventional Radiology 2024; 41(01): 027 doi: 10.1055/s-0043-1777716
|
14 |
Fei Xing, Ning Liu, Can Wang, Xu-Dong Wang. Caffeic acid phenethyl ester promotes oxaliplatin sensitization in colon cancer by inhibiting autophagy. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-65409-2
|